Cargando…
Rationale and design to assess the efficacy and safety of HT047 in patients with acute ischemic stroke: A multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase II trial
BACKGROUND: Though several neuroprotective agents have been evaluated as potential treatments for acute ischemic stroke, none have demonstrated a definitive treatment efficacy, which remains elusive. HT047 is an herbal extract of Scutellaria baicalensis and Pueraria lobata, both of which have been w...
Autores principales: | Heo, Sung Hyuk, Song, Jungbin, Kim, Bum Joon, Kim, Hocheol, Chang, Dae-Il |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824685/ https://www.ncbi.nlm.nih.gov/pubmed/31651889 http://dx.doi.org/10.1097/MD.0000000000017655 |
Ejemplares similares
-
Efficacy and safety of HT048 and HT077 for body fat and weight loss in overweight adults: A study protocol for a double-blind, randomized, placebo-controlled trial
por: Song, Jungbin, et al.
Publicado: (2019) -
Efficacy and safety of HT080 for lower urinary tract symptoms associated with benign prostatic hyperplasia: A study protocol for a randomized, double-blind, placebo-controlled trial
por: Song, Jungbin, et al.
Publicado: (2019) -
MLC901 in hypoxic-ischemic brain injury patients: A double-blind, randomized placebo-controlled pilot study
por: Pakdaman, Hossein, et al.
Publicado: (2023) -
CHADS(2), CHA(2)DS(2)-VASc, ATRIA, and Essen stroke risk scores in stroke with atrial fibrillation: A nationwide multicenter registry study
por: Yu, Inwu, et al.
Publicado: (2021) -
Acupuncture for amnestic mild cognitive impairment: A pilot multicenter, randomized, parallel controlled trial
por: Zhang, Jiayu, et al.
Publicado: (2021)